GLS and breast carcinoma: The gene expression profile revealed that the expression of FDX1, GLS, LIAS, LIPT1, MTF1, DLD, DLAT, and PDHA1 was downregulated, whereas the CDKN2A expression was upregulated in breast cancer in contrast with the normal tissue.